Moreover, it is generally accepted that the high expression of immune checkpoints such as CTLA4, PD-1, BTLA, CD274, and LAG3 will benefit tumor cells to escape immune surveillance, avoid immune-mediated apoptosis, and finally lead to poor prognosis [29, 30]. The gene discussed is CTLA4; the disease is neoplasm.